Navigation Links
Interleukin Genetics to Present Important New Findings at 2008 World Congress on Osteoarthritis
Date:9/15/2008

Genetic Variations Identify Predisposition to More Severe Knee

Osteoarthritis

WALTHAM, Mass., Sept. 15 /PRNewswire-FirstCall/ -- Interleukin Genetics, Inc. (Amex: ILI), announced today that Kenneth Kornman, Ph.D., the company's Chief Scientific Officer, will present important new research findings on the genetics of osteoarthritis (OA) at the 2008 World Congress on Osteoarthritis, sponsored by the Osteoarthritis Research Society International (OARSI). The 2008 World Congress on Osteoarthritis takes place Sept. 18-21, 2008, at the Rome Marriott Park Hotel in Rome, Italy.

Dr. Kornman will give an oral presentation, titled, "IL-1 RN Polymorphisms are Associated with Radiographic Severity in Osteoarthritis," on Sunday, Sept. 21, 2008 in the Tiziano B room at 9:50 a.m. CEST. In addition, new findings by Interleukin Genetics and collaborators, titled "Genetic Markers Associated with Generalized Osteoarthritis," will be presented during the poster session all day on Friday, Sept. 19, 2008, in the Foyer Tiziano room.

Dr. Kornman, Interleukin Genetics' Chief Scientific Officer and one of the authors of the two presentations, commented, "The new findings are based on a genetic test in development by Interleukin Genetics. The genetic test appears to identify knee OA patients who are likely to develop more severe joint destruction as they age. This information should be valuable in guiding the medical management of high risk patients and could be especially helpful in directing use of potential future disease modifying drugs for OA to achieve optimal benefit."

The new genetic findings are the result of research collaborations with Dr. Steven Abramson and Dr. Mukundan Attur of the New York
'/>"/>

SOURCE Interleukin Genetics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Interleukin Genetics Wins International Award for Outstanding Research Published in the Journal, Nutrition
2. Interleukin Genetics Launches Enhanced Heart Health Genetic Test Report Format
3. Video: The Journal, Human Genetics, Publishes Results Supporting Interleukin Genetics Heart Health Test
4. Genaera Announces MedImmune Initiation of Phase 2a Trial of Antibody Targeting Interleukin-9 in Patients with Asthma
5. MedImmune Advances Clinical Development of Antibody Targeting Interleukin-9 in Patients with Asthma
6. Phase 2a Multi-Dose Study Initiated by MedImmune in Patients With Asthma to Further Expand Anti-Interleukin-9 Program
7. Boston University and The Center for Human Genetics, Inc. Announce Change in Testing Services
8. New Research Provides Evidence that Tea May Improve Attention and Focus, Keep Brain Cells Healthy, & Influence Genetics in Cancer
9. Targeted Genetics Announces Positive Phase 1/2 tgAAC94 Data Presented at Annual European Congress of Rheumatology
10. CellCyte Genetics Corporation Selects Washington University School of Medicine to Perform Study on CellCytes Glycoprotein Products in Heart Attack Disease Model
11. CellCyte Genetics Signs Collaborative Agreement With Northwestern Universitys Feinberg School of Medicine to Perform Disease Model Outcome Study of CellCytes CCG-TH30 Product Candidate

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)..., LOVELAND,Colo.,Nov.25/PRNewswire-FirstCall/--He... advanceddiagnosticandspecialtyproductstotheveteri...nosticsCorporationforthesupplyofbloodgasproductsan..., (Logo: http://www.newscom.com/cgi-bin/prnh/20000...ssionforinnovatinginthefieldofadvancedpoint-of-car...
(Date:11/25/2009)..., EXTON,Pa.,Nov.25/PRNewswire/--BioTrendsResearch... Stelara report,thefirstinamulti-phasesyndicatedm...ho-Biotech,sStelara,fromproductlaunchthroughthefir...desquantitativeinformationfrom75uniqueDermatologis...rtsassesstrialanduseofStelara,obstaclestouse,typic...
(Date:11/25/2009)..., BASKINGRIDGE,N.J.,Nov.25/PRNewswire/--RegadoBio...tofantithromboticaptamerswithactivecontrolagents,a...resentingatthePiperJaffray21stAnnualHealthCareConf...o,spresentationwillbegivenat1:10pm(EST)onTuesday,D...linewithemphasisontheleaddevelopmentprogram,theant...
Breaking Medicine Technology:Heska Announces Supply Agreement With Roche Diagnostics 2Heska Announces Supply Agreement With Roche Diagnostics 3Despite Managed Care Obstacles, Interest and Anticipated Use of Centocor Ortho-Biotech's New Psoriasis Agent Stelara (ustekinumab) is High 2Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009 2Firm Parents Keep Teen Drivers Safe 58357 1Firm Parents Keep Teen Drivers Safe 58357 2Firm Parents Keep Teen Drivers Safe 58357 3Loyola University Chicago awarded scholarships for accelerated nursing students 58354 1Loyola University Chicago awarded scholarships for accelerated nursing students 58354 2M D Anderson scientist wins NIH New Innovator Award 58351 1M D Anderson scientist wins NIH New Innovator Award 58351 2M D Anderson scientist wins NIH New Innovator Award 58351 3
...in treating pediatric acute lymphoblastic,leukemia...ians treat,adolescents and adults with the disease... that has occurred in the cure rate for children w...ficult to replicate in older,patients without cons...cle,by St. Jude Children,s Research Hospital autho...
... NanoBio Corporation,announced today that it has ... its phase 2 study of NB-002, a topical lotion for... remain confidential, the results clearly,justify ...sts., "Allowing adequate time for subjects to gro... infection will enable us to generate data on,comp...
Other Medicine Technology:Molecular Science Could Further Improve Leukemia Survival, Say St. Jude Researchers 2NanoBio Corporation Completes Interim Analysis of Phase 2 Clinical Trial in Onychomycosis 2
(Date:11/25/2009)... who were treated with cisplatin-based chemotherap...ical side effects and Raynaud-like phenomena, than...ding to a new study published online November 25 i..., Marianne Brydy, M.D., of the Department of Onc...orway, and colleagues conducted a cross-sectional ...
(Date:11/25/2009)...f a collaboration between UCLA engineers and physi...0 million Americans who suffer from peripheral art...the arteries, peripheral arterial disease, or PAD,... arteries reduce blood flow to the limbs. The cond...e, heart attack and stroke, and its progression ca...
(Date:11/25/2009)...o draw definite conclusions, experts say, , ...iabetic patients with blocked coronary arteries, t...e year whether patients undergo bypass surgery or ...ort. , Bypass surgery has been the standard tre...disease. However, less invasive approaches such as...
(Date:11/25/2009)...reatment clinics to resume Monday, Nov. 30 , ... 2009 -- Centegra Health System is continuing to o... four Centegra Primary Care (CPC) vaccination clin... The clinics are at CPC sites in Huntley, Woodstoc...llows: ,   From 4:30 to 7:30 p.m. Tues...
(Date:11/25/2009)...mptoms, study finds , , WEDNESDAY, Nov....are among the potential problems faced by long-ter...with cisplatin-based chemotherapy, a new study has...n treated for unilateral testicular cancer between... conducted from 1998 to 2002. , The researchers...
Breaking Medicine News(10 mins):Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 3Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 4Health News:Stenting May Equal Bypass for Diabetic Heart Patients 2Health News:Stenting May Equal Bypass for Diabetic Heart Patients 3Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 2Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 3Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 4
...lity drugs to get pregnant can breathe a sigh of r...he popular medications used to increase the number...e do not increase the risk of ovarian cancer. // ...ad difficulty conceiving took fertility drugs and ...
...ated that Men who suffer from constipation are mor...in disease Parkinson's some have suggested that th...f the gut long before it manifests itself elsewher...high risk of developing the disease in the future....
...ng under polluted, hazy skies move away to communi...ore quickly, according to a study by researchers a...dicine researchers followed more than 100 children...affected annual rates of lung function growth, the...
...euths found that the absence of a certain protein ... water levels.Reported in the New England journal ...ey works.// The protein aquaporin-1has a d...ency of the protein have a limited ability to reab...
... bagged the registration, production and marketing...he Centre for Biotechnology in the Jawaharlal Nehr...e would be in the market in 3-4 months. The Compan...t to make any projections on the business the vacc...
...covered that frequent sexual intercourse can actua...attack.Middle aged men can have sex as many times/...f having a stroke, according to research. P...between sex and strokes. The team based its findin...
Other Medicine News:Health News:Particulate matter affects lung development 2
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
Medicine Products: